Holen Sie sich die Stockscreener-App
54.09
3.80%
2.01
Handel nachbörslich:
53.36
-0.73
-1.35%
Schlusskurs vom Vortag:
$52.08
Offen:
$51.95
24-Stunden-Volumen:
335.30K
Relative Volume:
0.77
Marktkapitalisierung:
$1.84B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$131.74M
KGV:
12.85
EPS:
4.21
Netto-Cashflow:
$166.13M
1W Leistung:
+2.31%
1M Leistung:
-4.74%
6M Leistung:
-21.01%
1J Leistung:
-19.30%
1-Tages-Spanne:
$51.92
$55.19
1-Wochen-Bereich:
$51.43
$55.19
52-Wochen-Spanne:
$46.00
$78.19
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Vergleichen Sie CNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
54.09 | 1.84B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
136.25 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.80 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.83 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.74 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.20 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-12 | Herabstufung | Needham | Buy → Hold |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
Needham Downgrades CONMED (CNMD) Stock - Insider Monkey
GAMMA Investing LLC Purchases 78,808 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Needham & Company LLC Downgrades CONMED (NYSE:CNMD) to Hold - MarketBeat
CONMED (NYSE:CNMD) Stock Price Down 5.2%Here's Why - MarketBeat
Conmed (CNMD) Downgraded by Needham Amidst Growth Concerns | CNM - GuruFocus
CONMED (NYSE:CNMD) Downgraded to Hold Rating by Needham & Company LLC - Defense World
LaVerne Council Now Leads CONMED Corporation’s Board of Directors - Medical Product Outsourcing
This Conagra Brands Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday - Benzinga
Demystifying Conmed: Insights From 5 Analyst Reviews - Benzinga
Needham downgrades Conmed stock rating on slower growth concerns - Investing.com
GAMMA Investing LLC Increases Stock Holdings in CONMED Co. (NYSE:CNMD) - Defense World
Ex-Dividend Reminder: Gilead Sciences, CONMED and Thermo Fisher Scientific - Nasdaq
Wedge Capital Management L L P NC Sells 10,031 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Sold by California State Teachers Retirement System - Defense World
ConMed to pay dividend for Q2 on July 3 - Central New York Business Journal
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $5.35 Million Stake in CONMED Co. (NYSE:CNMD) - MarketBeat
Squarepoint Ops LLC Takes $849,000 Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed (CNMD) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Nuveen Asset Management LLC Sells 59,427 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Brokerages Set CONMED Co. (NYSE:CNMD) Target Price at $62.20 - MarketBeat
Jane Street Group LLC Sells 33,640 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
3 Reasons to Sell CNMD and 1 Stock to Buy Instead - Yahoo Finance
CONMED Co. (NYSE:CNMD) Holdings Cut by Voloridge Investment Management LLC - MarketBeat
CONMED Co. (NYSE:CNMD) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 664 Shares of CONMED Co. (NYSE:CNMD) - Defense World
CONMED Co. (NYSE:CNMD) Shares Purchased by Deutsche Bank AG - MarketBeat
CONMED Co. (NYSE:CNMD) Plans $0.20 Quarterly Dividend - MarketBeat
CONMED (NYSE:CNMD) Is Due To Pay A Dividend Of $0.20 - Yahoo Finance
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - sharewise
Westwood Holdings Group Inc. Sells 4,708 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED names LaVerne Council as new board chair By Investing.com - Investing.com Canada
Conmed (CNMD) Names LaVerne Council as New Board Chair | CNMD Stock News - GuruFocus
CONMED names LaVerne Council as new board chair - Investing.com
CONMED Strengthens Leadership: Tech Veteran LaVerne Council Takes Board Chair Role in Strategic Refresh - Stock Titan
CONMED Sets $0.20 Dividend Payout: Key Dates for Shareholders to Secure Next Payment - Stock Titan
Gotham Asset Management LLC Makes New $313,000 Investment in CONMED Co. (NYSE:CNMD) - Defense World
Conmed (CNMD) Names LaVerne Council as New Board Chair | CNMD St - GuruFocus
D. E. Shaw & Co. Inc. Cuts Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Here's Why Conmed (CNMD) is a Strong Value Stock - Yahoo Finance
Ameriprise Financial Inc. Sells 4,101 Shares of CONMED Co. (NYSE:CNMD) - Defense World
ConMed announces executive changes - Central New York Business Journal
Northern Trust Corp Grows Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Silvercrest Asset Management Group LLC Takes $68.49 Million Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Hsbc Holdings PLC Sells 5,473 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Susquehanna International Group LLP Grows Position in CONMED Co. (NYSE:CNMD) - MarketBeat
The Manufacturers Life Insurance Company Lowers Stock Holdings in CONMED Co. (NYSE:CNMD) - Defense World
CNMD Q1 Earnings Call: Supply Chain Progress, Growth Drivers, and Tariff Mitigation in Focus - Yahoo Finance
Axa S.A. Acquires 6,500 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Purchased by Brevan Howard Capital Management LP - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Bought by First Trust Advisors LP - MarketBeat
Dean Capital Management Increases Stake in CONMED Co. (NYSE:CNMD) - MarketBeat
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Conmed Corp-Aktie (CNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Concannon Brian | Director |
Jun 03 '25 |
Option Exercise |
0.00 |
479 |
0 |
10,116 |
| Farkas Charles | Director |
Jun 03 '25 |
Option Exercise |
0.00 |
479 |
0 |
16,859 |
| Council LaVerne H | Director |
Jun 03 '25 |
Option Exercise |
0.00 |
479 |
0 |
4,048 |
| Bronson David M. | Director |
Jun 03 '25 |
Option Exercise |
0.00 |
479 |
0 |
17,241 |
| Aronson Martha Goldberg | Director |
Jun 03 '25 |
Option Exercise |
0.00 |
479 |
0 |
12,391 |
| Farkas Charles | Director |
May 29 '25 |
Option Exercise |
55.70 |
1,000 |
55,700 |
17,346 |
| Workman John L | Director |
May 20 '25 |
Option Exercise |
59.84 |
479 |
28,663 |
20,891 |
| Farkas Charles | Director |
May 05 '25 |
Sale |
56.94 |
4,000 |
227,768 |
16,346 |
4.52%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):